Recurrent Uterine Cancer


National Gynecologic Cancer Awareness Month on CancerConnect (September 9, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of cervical, ovarian and uterine cancer educational programs for national gynecologic cancer awareness month.... Continue Reading

Radiation for Uterine Cancer May Increase Risk of Bladder Cancer (January 8, 2014)

Radiation therapy used to treat uterine cancer may increase the risk of bladder cancer later in life, according to the results of a study published in BJU International. Uterine (endometrial) cancer is... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival... Continue Reading

Cancer Caregivers Devote Substantial Time and Effort (September 9, 2009)

On average, informal caregivers of cancer patients devote more than eight hours per day to caregiving. These results were published in Cancer. Informal caregiving is an important part of cancer management.... Continue Reading

Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers (March 17, 2008)

The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective as and more convenient than second-day... Continue Reading

Stress and Depression Frequent Among Women Treated for Gynecological Cancers (February 22, 2005)

Stress and Depression Frequent Among Women Treated for Gynecological Cancers According to the results of a study recently published in Gynecologic Oncology , women with gynecologic cancer often experience... Continue Reading

New Hormone Therapy, SERM LY353381, May Benefit Some Women with Advanced or Recurrent Endometrial Cancer (February 26, 2002)

New Hormone Therapy, SERM LY353381, May Benefit Some Women with Advanced or Recurrent Endometrial Cancer Preliminary study results on a new type of hormone therapy, currently known as SERM LY353381,... Continue Reading

Megestrol and Tamoxifen Combo Is Active against Recurrent or Advanced Endometrial Cancer (February 26, 2002)

Megestrol and Tamoxifen Combo Is Active against Recurrent or Advanced Endometrial Cancer A combination of megestrol acetate and tamoxifen may be more effective against advanced or recurrent cancer... Continue Reading

Doxorubicin/Paclitaxel and Doxorubicin/Cisplatin Are Equally Effective against Advanced or Recurrent Endometrial Cancer (February 26, 2002)

Doxorubicin/Paclitaxel and Doxorubicin/Cisplatin Are Equally Effective against Advanced or Recurrent Endometrial Cancer The chemotherapy combination of doxorubicin and paclitaxel appears to be equal... Continue Reading

Radical Radiation Therapy Regimen Produces Cure in More than Half of Women with Local Recurrence of Endometrial Cancer (February 26, 2002)

Radical Radiation Therapy Regimen Produces Cure in More than Half of Women with Local Recurrence of Endometrial Cancer The use of a combination of external-beam radiation therapy and brachytherapy... Continue Reading

Intensive Chemotherapy Is Effective for Women Previously Treated for Gestational Trophoblastic Tumors (February 26, 2002)

Intensive Chemotherapy Is Effective for Women Previously Treated for Gestational Trophoblastic Tumors Gestational trophoblastic tumors are rare but highly curable cancers that develop from the products... Continue Reading

Brachytherapy after Surgery Appears to Help Prevent Recurrences in Persons with Stage I Endometrial Cancer (February 26, 2002)

Brachytherapy after Surgery Appears to Help Prevent Recurrences in Persons with Stage I Endometrial Cancer The use of brachytherapy (radioactive implants) after surgery for stage I endometrial cancer... Continue Reading

Oral Etoposide Shows Modest Activity, with Minimal Side Effects, against Recurrent Endometrial Cancer (February 26, 2002)

Oral Etoposide Shows Modest Activity, with Minimal Side Effects, against Recurrent Endometrial Cancer Chemotherapy with oral etoposide may benefit women who have recurrent or metastatic endometrial... Continue Reading

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS